Collaborators Product Indication Funding Summary
National Institutes of Allergy and Infectious Diseases (NIAID) CEL-1000 Avian (bird) flu Testing conducted and paid for by NAID Testing conducted to determine whether CEL-1000 could be used as a potential treatment and/or preventative agent against this
Understand the change of gears now for the lab?
What makes this investment so exciting is the LEAPs and CEL 1000 platform potentially has so many applications.
And this platform has been in the works for many years, much to the chagrin of long time investors. Those who stayed with it will start to see more and more studies, and hopefully this connection with the Government and the pressing need for a therapeutic vaccine will finally allow all this research to come to fruition.
It also seems as if we're reading more and more about Immunotherapy. A coincidence? I think not.
The medical community has to be exasperated over the inroads made with all the toxic chemo therapy and drug cocktails.
Imagine, we possibly are sitting with a company that has a platform for for treatment of dozens of horrible diseases.
And speaking of coincidence, read this link.
And take note, special note of the 3rd to last paragraph.
so many possiblities...We just want to believe that. that's why we are with CVM now.
CVM can product Vaccine also. even though cell-1000 is not appoved, CDC let CVM product vaccine in the lab. still good for CVM value. I can't give up CVM till hearing bad news.
One more thing. I usually don't get into this but anyone questioning the "value". It's low. Very low. If we had a market cap of 1 Billion (4 times this price) it would still be rational.
And that's before what I expect to happen. So yeah, it's still on sale.
Just sock it away and be patient. Through bashers, dashers, sneezies, creepies etc
Buy and be patient. This is just the very beginning.
And I put my money where my mouth is.
Yesterday AM, when I made that call and added 25,000 shares at $1.26 I was pretty darn sure what I was doing. However, I'll accept it as dumb luck. :)
It info that's been here and available. A few people figured it out. I think the specialist and the shprts did yesterday when the news pf the RA paper hit the media links --they realized they had to start to cover if Sunday, others connect the dots. Just my op.
GL But it should be huge.
Here's the short version, in my opinion;
Months ago, the NIH (through NIAID) put Cel Sci on their radar screen, as a well connected scientist got wind of just what LEAPs and Cel 1000 are potentially capable of.
Geert has the lab being prepped for validation of MK as a priority. Guess why he changes "gears" and now H1 N1 is a priority?
Getting the picture?
It's their meal ticket now. MK yes, but now they have a collaborator in the US Govt ! Money, assistance and an architect to follow for the new validation effort. Soon to be inspected and approved for CVM AND Govt use.
Just my op, but put all the pieces together.
I may not have it all put together but I'm pretty sure it's close.